Cargando…
Towards a psychobiotic therapy for depression: Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice
BACKGROUND: Accumulating evidence points to an association between gut microbial abnormalities and depression disorder. The microbiota-gut-brain axis is an emerging target for treating depression using nutritional strategies, considering the numerous limitations of current pharmacological approaches...
Autores principales: | Tian, Peijun, O'Riordan, Kenneth J., Lee, Yuan-kun, Wang, Gang, Zhao, Jianxin, Zhang, Hao, Cryan, John F., Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109524/ https://www.ncbi.nlm.nih.gov/pubmed/32258258 http://dx.doi.org/10.1016/j.ynstr.2020.100216 |
Ejemplares similares
-
Bifidobacterium breve CCFM1025 Improves Sleep Quality via Regulating the Activity of the HPA Axis: A Randomized Clinical Trial
por: Lan, Yuming, et al.
Publicado: (2023) -
Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease
por: Li, Tiantian, et al.
Publicado: (2022) -
Dose–Response Efficacy and Mechanisms of Orally Administered Bifidobacterium breve CCFM683 on IMQ-Induced Psoriasis in Mice
por: Chen, Xinqi, et al.
Publicado: (2023) -
Lactobacillus paracasei CCFM1229 and Lactobacillus rhamnosus CCFM1228 Alleviated Depression- and Anxiety-Related Symptoms of Chronic Stress-Induced Depression in Mice by Regulating Xanthine Oxidase Activity in the Brain
por: Xu, Mengshu, et al.
Publicado: (2022) -
The efficacy psychobiotics for depression treatment
por: Denysov, Y., et al.
Publicado: (2023)